BioSpace News Archive

Drug Development

Cybrexa Therapeutics Presents Preclinical Data Demonstrating its alphalex™ Tumor Targeting Platform Delivers a High Dose of PARP Inhibitor in Combination with Chemotherapy

Cybrexa Therapeutics, a biotechnology company developing a new class of cancer therapeutics through its alphalex™ tumor targeting platform, today announced that the company presented preclinical data regarding the alphalex™ platform’s application to a poly (ADP- ribose) polymerase (PARP) inhibitor.

November 13, 2018
·
2 min read
Estrogen Replacement Accounts for Over 80% of Hormone Replacement Therapy Market Revenues

The hormone replacement therapy market is foreseen to expand at a significant pace with sales of products crossing US$ 12,000 Mn by 2019 end

November 13, 2018
·
3 min read
Policy

Merck Begins Rolling Submission of Licensure Application for V920 (rVSV∆G-ZEBOV-GP) to U.S. Food and Drug Administration

V920 is the Company’s Investigational Vaccine for Ebola Zaire

November 13, 2018
·
5 min read
Business

Electromed, Inc. Announces Fiscal 2019 First Quarter Financial Results

Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2018 (“Q1 FY 2019”).

November 13, 2018
·
9 min read
Pharm Country

DEFINED HEALTH BECOMES CELLO HEALTH BIOCONSULTING, DEMONSTRATING CELLO’S COMMITMENT TO US BIOTECH STRATEGY

Defined Health, a leading business development strategy consulting firm with a particular focus in early stage biotech announced today that it has changed its name to Cello Health BioConsulting.

November 13, 2018
·
3 min read
GamaMabs Pharma to present new data on GM102 at two upcoming scientific conferences in November

GamaMabs Pharma, a biotechnology company developing optimized therapeutic antibodies targeting the Anti-Müllerian Hormone Receptor II (AMHRII) for the treatment of cancer, today announces its presentation of new data regarding its First-In-Class GM102 antibody at two upcoming conferences.

November 13, 2018
·
3 min read
BOC Sciences Recently Updates Its Metabolites and Impurities Collection

Starting from the year of 2013, BOC Sciences has been providing a wide variety of metabolites and impurities for scientists in the research community.

November 13, 2018
·
2 min read
Business

Lifeloc Reports Third Quarter 2018 Results

Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol testing devices, has announced financial results for the third quarter ended September 30, 2018.

November 13, 2018
·
8 min read
Business

GeneNews Announces Third Quarter 2018 Results Investor Call

Conference Call – 8:30am Thursday, November 15th

November 13, 2018
·
2 min read
Job Trends

LifeCare Home Care Agencies Earn National Recognition

LifeCare Health Partners is pleased to announce nine of its Home Care providers have been included on the annual HomeCare Elite® list.

November 13, 2018
·
2 min read